Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.

Prokofyeva D, Bogdanova N, Dubrowinskaja N, Bermisheva M, Takhirova Z, Antonenkova N, Turmanov N, Datsyuk I, Gantsev S, Christiansen H, Park-Simon TW, Hillemanns P, Khusnutdinova E, Dörk T.

Breast Cancer Res Treat. 2013 Jan;137(2):533-9. doi: 10.1007/s10549-012-2357-1. Epub 2012 Dec 6.

PMID:
23225144
2.

A common nonsense mutation of the BLM gene and prostate cancer risk and survival.

Antczak A, Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dębniak T, Masojć B, Górski B, Gromowski T, Nagorna A, Gołąb A, Sikorski A, Słojewski M, Gliniewicz B, Borkowski T, Borkowski A, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Domagała P, Stawicka M, Milecki P, Akbari MR, Narod SA, Lubiński J, Cybulski C; Polish Hereditary Prostate Cancer Consortium; Other members of the Polish Hereditary Prostate Cancer Consortium, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała W, Chosia M, van de Wetering T, Serrano-Fernández P, Puszyński M, Soczawa M, Switała J, Archimowicz S, Kordowski M, Zyczkowski M, Borówka A, Bagińska J, Krajka K, Szwiec M, Haus O, Janiszewska H, Stembalska A, Sąsiadek MM.

Gene. 2013 Dec 15;532(2):173-6. doi: 10.1016/j.gene.2013.09.079. Epub 2013 Oct 2.

PMID:
24096176
3.

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.

Bogdanova N, Togo AV, Ratajska M, Kluźniak W, Takhirova Z, Tarp T, Prokofyeva D, Bermisheva M, Yanus GA, Gorodnova TV, Sokolenko AP, Kuźniacka A, Podolak A, Stukan M, Wokołorczyk D, Gronwald J, Vasilevska D, Rudaitis V, Runnebaum IB, Dürst M, Park-Simon TW, Hillemanns P, Antonenkova N, Khusnutdinova E, Limon J, Lubinski J, Cybulski C, Imyanitov E, Dörk T.

Fam Cancer. 2015 Mar;14(1):145-9. doi: 10.1007/s10689-014-9748-x.

PMID:
25182961
4.

A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.

Bogdanova N, Cybulski C, Bermisheva M, Datsyuk I, Yamini P, Hillemanns P, Antonenkova NN, Khusnutdinova E, Lubinski J, Dörk T.

Breast Cancer Res Treat. 2009 Nov;118(1):207-11. doi: 10.1007/s10549-008-0189-9. Epub 2008 Sep 21.

PMID:
18807267
5.

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.

Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, Kuligina ESh, Gorodnova TV, Pfeifer W, Togo AV, Turkevich EA, Ivantsov AO, Voskresenskiy DV, Dolmatov GD, Bit-Sava EM, Matsko DE, Semiglazov VF, Fichtner I, Larionov AA, Kuznetsov SG, Antoniou AC, Imyanitov EN.

Int J Cancer. 2012 Jun 15;130(12):2867-73. doi: 10.1002/ijc.26342. Epub 2011 Oct 20.

6.

Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.

Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, Togo AV, Lubiński J, Cybulski C, Jakubowska A, Dörk T, Imyanitov EN.

Breast Cancer Res Treat. 2014 Jun;145(2):553-62. doi: 10.1007/s10549-014-2971-1. Epub 2014 May 7.

PMID:
24800916
7.

The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia.

Imyanitov E, Prokofyeva D, Bogdanova N, Dörk T.

Breast Cancer Res Treat. 2014 Dec;148(3):695-6. doi: 10.1007/s10549-014-3198-x. No abstract available.

PMID:
25410042
8.

The frequency of the BLM p.Q548X (c.1642C>T) mutation in breast cancer patients from Russia is no higher than in the general population.

Anisimenko MS, Kozyakov AE, Paul GA, Kovalenko SP.

Breast Cancer Res Treat. 2014 Dec;148(3):689-90. doi: 10.1007/s10549-014-3187-0. Epub 2014 Nov 16. No abstract available.

PMID:
25399228
9.

Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.

Kohlhase S, Bogdanova NV, Schürmann P, Bermisheva M, Khusnutdinova E, Antonenkova N, Park-Simon TW, Hillemanns P, Meyer A, Christiansen H, Schindler D, Dörk T.

PLoS One. 2014 Jan 21;9(1):e85334. doi: 10.1371/journal.pone.0085334. eCollection 2014.

10.

A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women.

Wang Z, Xu Y, Tang J, Ma H, Qin J, Lu C, Wang X, Hu Z, Wang X, Shen H.

Breast Cancer Res Treat. 2009 Nov;118(1):169-75. doi: 10.1007/s10549-009-0327-z. Epub 2009 Feb 10.

PMID:
19205873
11.

Genomic instability and cancer: lessons from analysis of Bloom's syndrome.

Payne M, Hickson ID.

Biochem Soc Trans. 2009 Jun;37(Pt 3):553-9. doi: 10.1042/BST0370553.

PMID:
19442250
12.

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.

Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H; kConFab, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH, Mitchell G, Campbell IG.

PLoS Genet. 2012 Sep;8(9):e1002894. doi: 10.1371/journal.pgen.1002894. Epub 2012 Sep 27.

13.

Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.

Broberg K, Huynh E, Schläwicke Engström K, Björk J, Albin M, Ingvar C, Olsson H, Höglund M.

BMC Cancer. 2009 May 11;9:140. doi: 10.1186/1471-2407-9-140.

14.

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.

Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Hillemanns P, Dörk T.

Clin Genet. 2010 Oct;78(4):364-72. doi: 10.1111/j.1399-0004.2010.01473.x.

PMID:
20569256
15.

The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.

Laitman Y, Boker-Keinan L, Berkenstadt M, Liphsitz I, Weissglas-Volkov D, Ries-Levavi L, Sarouk I, Pras E, Friedman E.

Cancer Genet. 2016 Mar;209(3):70-4. doi: 10.1016/j.cancergen.2015.12.006. Epub 2015 Dec 22.

PMID:
26778106
16.

[Frequency of CHEK2 gene mutations in patients with breast cancer from the Republic of Bashkortostan].

[No authors listed]

Mol Biol (Mosk). 2014 Jan-Feb;48(1):55-61. Russian.

PMID:
25842825
17.

The contribution of founder mutations in BRCA1 to breast cancer in Belarus.

Uglanitsa N, Oszurek O, Uglanitsa K, Savonievich E, Lubiński J, Cybulski C, Debniak T, Narod SA, Gronwald J.

Clin Genet. 2010 Oct;78(4):377-80. doi: 10.1111/j.1399-0004.2010.01439.x.

PMID:
20507347
18.

Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.

Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, Lin YH, Wu PE, Shen CY.

Carcinogenesis. 2009 Jan;30(1):43-9. doi: 10.1093/carcin/bgn233. Epub 2008 Oct 28.

19.

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.

Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B.

Carcinogenesis. 2006 Aug;27(8):1655-60. Epub 2006 Feb 25.

20.

Heterozygosity for the BLM(Ash) mutation and cancer risk.

Cleary SP, Zhang W, Di Nicola N, Aronson M, Aube J, Steinman A, Haddad R, Redston M, Gallinger S, Narod SA, Gryfe R.

Cancer Res. 2003 Apr 15;63(8):1769-71.

Items per page

Supplemental Content

Write to the Help Desk